CTVA

Corteva, Inc. (CTVA)

Last Price$61.50.9%
Market Cap$42.5B
LTM Operating Income
$1,963.0M
YoY Growth
+50.9%
3Y CAGR
+16.0%
5Y CAGR
-5.9%
Stock quality & Intrinsic value
7/10
39.2% overvalued

Corteva, Inc. Operating Income

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Operating Income
$886.0M
$188.0M
$1,290.0M
$799.0M
$1,055.0M
$2,665.0M
$1,868.0M
$2,110.0M
CTVA
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CTVA and see if it's the right time to invest.
Dive in

Corteva, Inc. (CTVA) Operating Income comparison analysis

Crunching data... Almost there!

CTVA key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Corteva, Inc.'s Operating Income?

As of today, Corteva, Inc.'s last 12-month Operating Income is $1,963.0M, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Corteva, Inc.'s Operating Income growth rate?

Over the last year, Corteva, Inc.'s Operating Income growth was 50.9%. The average annual Operating Income growth rates for Corteva, Inc. have been 28.9% over the past three years, (5.9%) over the past five years.

3) Is Corteva, Inc.'s Operating Income growth rate Good?

Over the last year, Corteva, Inc.'s Operating Income growth was 50.9%, which is higher than industry growth of (0.3%). It indicates that Corteva, Inc.'s Operating Income growth is Good.

4) How does Corteva, Inc.'s Operating Income growth rate compare to its peers?

Over the last year, Corteva, Inc.'s Operating Income growth was 50.9%, which is higher than peer median growth of 43.2%. The list of peers includes CF, NTR, MOS, ICL, FMC, SMG, UAN, BIOX, LVRO, IPI etc.